Speaker illustration

Doctor Alessandro Candreva

University Hospital Zurich, Zurich (Switzerland)

Member of:

European Society of Cardiology

Thanks to a pliant mentality and a ready mobility, I enriched my medical training at San Raffaele University (Milan, IT) by visiting fellowships throughout Europe (Thoraxcentrum- Rotterdam, NL; Charité- Berlin, DE). In November 2014 I started the Swiss residency program for cardiology at the University Heart Centre (Zurich, CH). In Switzerland, my passion for clinical research bloomed. While pushing forward my interest for coronary intervention, in Zurich I was involved in several research projects on percutaneous valves (MitraClip, TAVI) and clinical cardiology (HF, ACS, Takotsubo). Moreover, I was part of the pre-clinical development of two novel devices (Cardioband and TriCinch), which have now entered the clinical practice. Together with the machine-learning institute at the ETH, we established the SWISSHEART Network with the aim to apply artificial intelligent in cardiovascular science. We were awarded with the prestigious SPHN/PHRT Grant 2018.

Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage: a post hoc analysis from the CLEVER-ACS trial

Event: ESC Congress 2024

Topic: Angiography, Invasive Imaging

Session: Risk stratification for midterm outcome after acute coronary syndromes

Thumbnail

Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.

Event: ESC Congress 2020

Topic: Invasive Imaging and Functional Assessment

Session: Interventional Cardiology ePosters

Thumbnail

Machine learning for improving risk stratification after ACS

Event: ESC Congress 2018

Topic: Cardiovascular Risk Assessment

Session: Secondary prevention

Thumbnail